@ppnhuyy_1503: yeu anh#seatawinan #jimmysea #fyp #xhuong #xuhuongtiktok

jimmyseaa
jimmyseaa
Open In TikTok:
Region: VN
Wednesday 23 September 2026 10:44:24 GMT
1118
359
4
27

Music

Download

Comments

_wo0kynq
J. :
xin up nki đc k ạ hjhj
2026-09-24 04:56:15
0
cte.dthuongs2tg
𝙣𝙖𝙖 𝙢𝙚𝙤~ :
Sea kawai~~
2026-09-23 10:51:12
0
_.dkstjxx
sua chua viet quat :
@m phg 😳
2026-09-24 05:08:45
0
To see more videos from user @ppnhuyy_1503, please go to the Tikwm homepage.

Other Videos

Not all thyroid cancers are the same—and the distinction matters when prescribing GLP-1 medications. The FDA labeling for Wegovy lists these thyroid-related contraindications: • A personal history of medullary thyroid carcinoma • A family history of medullary thyroid carcinoma • Multiple Endocrine Neoplasia syndrome type 2, or MEN2 Papillary thyroid cancer is a different type of cancer arising from different thyroid cells. A family history of papillary thyroid cancer, by itself, is not listed as a contraindication to Wegovy. That does not mean family history should be ignored. The appropriate next steps are to: • Confirm the relative’s exact diagnosis • Review available pathology or medical records when possible • Assess the patient’s complete personal and family history • Discuss risks, benefits and alternative treatments • Evaluate concerning thyroid symptoms or nodules appropriately “Thyroid cancer” is not specific enough. Before starting or stopping treatment, we need to know which type. Save this post and share it with someone who has questions about GLP-1 medications and thyroid cancer. Sources: Current Wegovy Prescribing Information and the National Cancer Institute. Educational information only. This does not establish that Wegovy is appropriate for any specific person. Patients should not start, restart or discontinue prescribed medication without discussing their individual circumstances with a qualified healthcare professional. #Wegovy #Semaglutide #GLP1 #ThyroidCancer      #creatorsearchinsights
Not all thyroid cancers are the same—and the distinction matters when prescribing GLP-1 medications. The FDA labeling for Wegovy lists these thyroid-related contraindications: • A personal history of medullary thyroid carcinoma • A family history of medullary thyroid carcinoma • Multiple Endocrine Neoplasia syndrome type 2, or MEN2 Papillary thyroid cancer is a different type of cancer arising from different thyroid cells. A family history of papillary thyroid cancer, by itself, is not listed as a contraindication to Wegovy. That does not mean family history should be ignored. The appropriate next steps are to: • Confirm the relative’s exact diagnosis • Review available pathology or medical records when possible • Assess the patient’s complete personal and family history • Discuss risks, benefits and alternative treatments • Evaluate concerning thyroid symptoms or nodules appropriately “Thyroid cancer” is not specific enough. Before starting or stopping treatment, we need to know which type. Save this post and share it with someone who has questions about GLP-1 medications and thyroid cancer. Sources: Current Wegovy Prescribing Information and the National Cancer Institute. Educational information only. This does not establish that Wegovy is appropriate for any specific person. Patients should not start, restart or discontinue prescribed medication without discussing their individual circumstances with a qualified healthcare professional. #Wegovy #Semaglutide #GLP1 #ThyroidCancer #creatorsearchinsights

About